Literature DB >> 10233562

Review. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine.

G Kobelt1, I Kirchberger, J Malone-Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233562     DOI: 10.1046/j.1464-410x.1999.00004.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  21 in total

1.  CUA guideline on adult overactive bladder.

Authors:  Jacques Corcos; Mikolaj Przydacz; Lysanne Campeau; Gary Gray; Duane Hickling; Christiane Honeine; Sidney B Radomski; Lynn Stothers; Adrian Wagg; Frcp Lond
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

Review 2.  Efficacy and safety of imidafenacin for overactive bladder in adult: a systematic review and meta-analysis.

Authors:  Wei Huang; Huantao Zong; Xin Zhou; Yong Zhang
Journal:  Int Urol Nephrol       Date:  2015-01-31       Impact factor: 2.370

Review 3.  Disease burden of overactive bladder: quality-of-life data assessed using ICI-recommended instruments.

Authors:  Ramandeep Basra; Con Kelleher
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Establishing the content validity of the King's Health Questionnaire in men and women with overactive bladder in the US.

Authors:  Mary Kay Margolis; Vasudha Vats; Karin S Coyne; Con Kelleher
Journal:  Patient       Date:  2011       Impact factor: 3.883

5.  Defining efficacy in the treatment of overactive bladder syndrome.

Authors:  Sagar Shah; Victor W Nitti
Journal:  Rev Urol       Date:  2009

6.  Vesical pacing in patients with overactive bladder: technique and results.

Authors:  Ahmed Shafik; Ismail Shafik; Olfat el-Sibai; Ali Shafik; Randa M Mostafa
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 7.  Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q.

Authors:  K Coyne; D Revicki; T Hunt; R Corey; W Stewart; J Bentkover; H Kurth; P Abrams
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

9.  Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial.

Authors:  Y Homma; K Kawabe
Journal:  World J Urol       Date:  2004-09-29       Impact factor: 4.226

10.  The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis.

Authors:  Tracey Young; Yaling Yang; John E Brazier; Aki Tsuchiya; Karin Coyne
Journal:  Qual Life Res       Date:  2008-12-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.